| nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
| 1 |
A420983, a novel, small molecule inhibitor of LCK prevents allograft rejection
|
Waegell, W
|
|
2002
|
34 |
5 |
p. 1411-1417
|
artikel
|
| 2 |
A cause of late graft dysfunction after pediatric liver transplantation: de novo autoimmune hepatitis
|
Petz, W
|
|
2002
|
34 |
5 |
p. 1958-1959
|
artikel
|
| 3 |
ACEi-induced attenuation of platelet TIMP-1 production in renal allograft recipients. possible impact on erythropoiesis
|
Lightfoot, B.O
|
|
2002
|
34 |
5 |
p. 1806-1807
|
artikel
|
| 4 |
A cost-effectiveness analysis of tacrolimus versus cyclosporine microemulsion following kidney transplantation
|
Craig, A.-M
|
|
2002
|
34 |
5 |
p. 1646-1648
|
artikel
|
| 5 |
Acute rejection after renal transplantation with tacrolimus-based therapy in conditions of normal clinical practice
|
Scolari, M.P
|
|
2002
|
34 |
5 |
p. 1671-1672
|
artikel
|
| 6 |
Adverse events in renal transplantation under tacrolimus/mycophnolate mofetil immunosuppression: a single-center experience
|
Omoto, K
|
|
2002
|
34 |
5 |
p. 1821-1822
|
artikel
|
| 7 |
Almost total absence of chronic rejection in primary pediatric liver transplantation under tacrolimus
|
Jain, A
|
|
2002
|
34 |
5 |
p. 1968-1969
|
artikel
|
| 8 |
Alterations in calcineurin phosphatase activity in tacrolimus-treated renal transplant patients
|
Koefoed-Nielsen, P.B
|
|
2002
|
34 |
5 |
p. 1743-1744
|
artikel
|
| 9 |
Altered PTHrP expression during cold storage with thymoglobulin
|
Hu, M
|
|
2002
|
34 |
5 |
p. 1629-1631
|
artikel
|
| 10 |
Alternative immunosuppression for acute renal failure in liver transplantation: role of ultra–low dose tacrolimus and basiliximab
|
Varo, E
|
|
2002
|
34 |
5 |
p. 1533-1534
|
artikel
|
| 11 |
A multicenter, open-label, comparative trial of two daclizumab dosing strategies versus no antibody induction in simultaneous kidney-pancreas transplantation: 6-month interim analysis
|
Stratta, R.J
|
|
2002
|
34 |
5 |
p. 1903-1905
|
artikel
|
| 12 |
Analysis of trends in hospital readmissions and postoperative complications in heart transplant recipients: single center study
|
Donovan, M.P
|
|
2002
|
34 |
5 |
p. 1853-1854
|
artikel
|
| 13 |
Analysis of well-being after organ transplantation in a large cohort of french patients
|
Pageaux, G.P
|
|
2002
|
34 |
5 |
p. 1687-1688
|
artikel
|
| 14 |
Angiotensin II type 1 receptor blockade after cardiac transplantation reduced the incidence and severity of transplant vasculopathy in an animal-based study
|
Richter, M.H.C
|
|
2002
|
34 |
5 |
p. 1484-1485
|
artikel
|
| 15 |
A novel scale of immunosuppression exposure and correlation to outcomes after renal transplantation
|
Morrissey, P.E
|
|
2002
|
34 |
5 |
p. 1640-1641
|
artikel
|
| 16 |
A novel tacrolimus dosing strategy in cardiac transplantation: drug levels, renal function, and biopsy results
|
Baran, D.A
|
|
2002
|
34 |
5 |
p. 1834-1835
|
artikel
|
| 17 |
Antilymphocyte induction is no longer necessary in simultaneous pancreas and kidney transplantation
|
Rigotti, P
|
|
2002
|
34 |
5 |
p. 1906-1908
|
artikel
|
| 18 |
A paired study comparing the efficacy of renal preservation by normothermic autologous blood perfusion and hypothermic pulsatile perfusion
|
Metcalfe, M.S
|
|
2002
|
34 |
5 |
p. 1473-1474
|
artikel
|
| 19 |
A pilot trial of tacrolimus, sirolimus, and steroids in renal transplant recipients
|
Shapiro, R
|
|
2002
|
34 |
5 |
p. 1651-1652
|
artikel
|
| 20 |
A predictive model for chronic allograft nephropathy
|
Cardinal, H
|
|
2002
|
34 |
5 |
p. 1810-1811
|
artikel
|
| 21 |
A randomised trial comparing the efficacy and safety of tacrolimus with microemulsified cyclosporine after liver transplantation
|
Timmermann, W
|
|
2002
|
34 |
5 |
p. 1516-1518
|
artikel
|
| 22 |
A randomized prospective double-blind placebo-controlled study of gallopamil, calcium antagonist of the verapamil type, in stable cyclosporine-treated renal transplant recipients
|
Gossmann, J
|
|
2002
|
34 |
5 |
p. 1767-1770
|
artikel
|
| 23 |
A randomized trial of mycophenolate mofetil versus azathioprine as calcineurin inhibitor sparing agents in the treatment of chronic allograft nephropathy
|
Metcalfe, M.S
|
|
2002
|
34 |
5 |
p. 1812-1814
|
artikel
|
| 24 |
A removable tubing for implanting islet graft and studying immunosuppression
|
Hsu, B.R.-S
|
|
2002
|
34 |
5 |
p. 1462
|
artikel
|
| 25 |
Are reduced tacrolimus dosages needed in the early postoperative period following living donor liver transplantation in adults?
|
Troisi, R
|
|
2002
|
34 |
5 |
p. 1531-1532
|
artikel
|
| 26 |
A retrospective analysis of a sirolimus/prograf regimen for the prevention of acute rejection in recipients of primary mismatched renal allografts
|
Youseff, N
|
|
2002
|
34 |
5 |
p. 1653-1655
|
artikel
|
| 27 |
A three arm study comparing immediate tacrolimus therapy with ATG induction therapy followed by either tacrolimus or cyclosporine in adult renal transplant recipients
|
Charpentier, B
|
|
2002
|
34 |
5 |
p. 1625-1626
|
artikel
|
| 28 |
Author index
|
|
|
2002
|
34 |
5 |
p. 1979-1984
|
artikel
|
| 29 |
Azathioprine toxicity and thiopurine methyltransferase genotype in renal transplant patients
|
Pandya, B
|
|
2002
|
34 |
5 |
p. 1642-1645
|
artikel
|
| 30 |
Benelux experience with a combination of tacrolimus and mycophenolate mofetil: 4-year results
|
van Hooff, J.P.
|
|
2002
|
34 |
5 |
p. 1591-1593
|
artikel
|
| 31 |
Calcineurin inhibitor–free immunosuppressive regimen for marginal donors/recipients of kidney transplantation
|
Donati, D
|
|
2002
|
34 |
5 |
p. 1678-1680
|
artikel
|
| 32 |
Calcineurin inhibitors are not antagonistic to tolerance induction
|
Cosimi, A.B
|
|
2002
|
34 |
5 |
p. 1376-1377
|
artikel
|
| 33 |
Calcineurin-inhibitor withdrawal in heart transplantation recipients (the case against)
|
Mehra, M.R
|
|
2002
|
34 |
5 |
p. 1825-1827
|
artikel
|
| 34 |
Can acute rejection be prevented in SPK transplantation?
|
Burke, G.W
|
|
2002
|
34 |
5 |
p. 1913-1914
|
artikel
|
| 35 |
Can the immunosupressive effect of perioperative single high-dose antithymocyte globulin administration in kidney allograft recipients be due to apoptosis of activated lymphocytes?
|
Rowiński, W.
|
|
2002
|
34 |
5 |
p. 1622-1624
|
artikel
|
| 36 |
Cardiac allograft vasculopathy:
|
Weis, M
|
|
2002
|
34 |
5 |
p. 1847-1849
|
artikel
|
| 37 |
Cardiovascular risk factors in liver allograft recipients: relationship with immunosuppressive therapy
|
Varo, E
|
|
2002
|
34 |
5 |
p. 1553-1554
|
artikel
|
| 38 |
CD26 expression and enzymatic activity in recipients of kidney allografts
|
Korom, S
|
|
2002
|
34 |
5 |
p. 1753-1754
|
artikel
|
| 39 |
CD62–PSGL-1 interactions regulate cytokine chemokine and apoptotic networks in cardiac allograft recipients
|
Coito, A.J.
|
|
2002
|
34 |
5 |
p. 1463-1464
|
artikel
|
| 40 |
CD25+ regulatory cells generated by intratracheal delivery of alloantigen
|
Akiyama, Y
|
|
2002
|
34 |
5 |
p. 1443-1444
|
artikel
|
| 41 |
CD40 triggered human monocyte-derived dendritic cells convert to tolerogenic dendritic cells when JAK3 activity is inhibited
|
Säemann, M.D
|
|
2002
|
34 |
5 |
p. 1407-1408
|
artikel
|
| 42 |
Changes in renal function in long-term survivors of liver transplantation: a comparison between cyclosporine microemulsion and tacrolimus therapy
|
Charco, R
|
|
2002
|
34 |
5 |
p. 1548-1549
|
artikel
|
| 43 |
Chronic rejection and graft half-life: five-year follow-up of the european tacrolimus multicenter renal study
|
Mayer, A.D
|
|
2002
|
34 |
5 |
p. 1491-1492
|
artikel
|
| 44 |
clinical benefit of monitoring cyclosporine C2 and C4 in long-term liver transplant recipients
|
Barakat, O
|
|
2002
|
34 |
5 |
p. 1535-1537
|
artikel
|
| 45 |
Clinically significant drug interaction between basiliximab and tacrolimus in renal transplant recipients
|
Sifontis, N.M
|
|
2002
|
34 |
5 |
p. 1730-1732
|
artikel
|
| 46 |
Clinical observation on hemophilia a treatment by cadaveric spleen transplantation
|
Xiang, W.Z
|
|
2002
|
34 |
5 |
p. 1929-1931
|
artikel
|
| 47 |
CMV retinitis after renal transplantation
|
Shimakawa, M
|
|
2002
|
34 |
5 |
p. 1790-1792
|
artikel
|
| 48 |
Combined therapy of CTLA4Ig-gene transfection with FTY720 administration in rat lung allografts
|
Kita, Y
|
|
2002
|
34 |
5 |
p. 1437-1440
|
artikel
|
| 49 |
Comparison of tacrolimus and neoral-based immunosuppressive regimens in renal transplantation patients: singles-center experience
|
Gurkan, A
|
|
2002
|
34 |
5 |
p. 1661-1662
|
artikel
|
| 50 |
Comparison of the therapeutic effects between CsA and FK506 on chronic renal allograft injury and TGF-β expression
|
Miyagi, M
|
|
2002
|
34 |
5 |
p. 1589-1590
|
artikel
|
| 51 |
Complete withdrawal of immunosuppression in living donor liver transplantation
|
Oike, F
|
|
2002
|
34 |
5 |
p. 1521
|
artikel
|
| 52 |
Conversion from cyclosporine to tacrolimus is preferred by pediatric renal transplant recipients: a focus on opinions and outcomes
|
Sundberg, A.K
|
|
2002
|
34 |
5 |
p. 1951-1952
|
artikel
|
| 53 |
Conversion of cyclosporine to tacrolimus for refractory or persistent myocardial rejection
|
Chan, M.C.Y
|
|
2002
|
34 |
5 |
p. 1850-1852
|
artikel
|
| 54 |
Conversion to tacrolimus immunosuppression in renal transplant recipients: 12-month follow-up
|
Citterio, F
|
|
2002
|
34 |
5 |
p. 1685-1686
|
artikel
|
| 55 |
Corticosteroid elimination in renal transplantation: pro
|
Woodle, E.S
|
|
2002
|
34 |
5 |
p. 1693
|
artikel
|
| 56 |
Cyclooxygenase-2 inhibitor induces operational tolerance to fully allogenic cardiac grafts
|
Yokoyama, T
|
|
2002
|
34 |
5 |
p. 1405-1406
|
artikel
|
| 57 |
Cyclophosphamide-induced postoperative anemia in cynomolgus monkey recipients of hdaf-transgenic pig organ xenografts
|
Lam, T.T
|
|
2002
|
34 |
5 |
p. 1451-1452
|
artikel
|
| 58 |
Cyclosporin a does not enhance the development of transplant vasculopathy: experimental study in a rat cardiac transplant model
|
Richter, M.H.C
|
|
2002
|
34 |
5 |
p. 1479-1480
|
artikel
|
| 59 |
Cyclosporine absorption profiling and therapeutic drug monitoring using c2 blood levels in stable renal allograft recipients
|
Einecke, G
|
|
2002
|
34 |
5 |
p. 1738-1739
|
artikel
|
| 60 |
cyclosporine-based quadruple induction therapy versus tacrolimus-based dual immunosuppression after liver transplantation: ten-year follow-up
|
Jonas, S
|
|
2002
|
34 |
5 |
p. 1504-1506
|
artikel
|
| 61 |
Cyclosporine does not influence serum cholesterol in kidney transplant recipients
|
Matzkies, F.K
|
|
2002
|
34 |
5 |
p. 1795-1796
|
artikel
|
| 62 |
Daclizumab and ATG versus ATG in combination with tacrolimus, mycophenolate mofetil, and steroids in simultaneus pancreas-kidney transplantation: analysis of early outcome
|
Dette, K
|
|
2002
|
34 |
5 |
p. 1909-1910
|
artikel
|
| 63 |
Delay of hepatitis c recurrence in liver transplant recipients: impact of mycophenolate mofetil on transplant recipients with severe acute rejection or with renal dysfunction
|
Fasola, C.G
|
|
2002
|
34 |
5 |
p. 1561-1562
|
artikel
|
| 64 |
De novo breast cancer in renal transplant recipients
|
Buell, J.F
|
|
2002
|
34 |
5 |
p. 1778-1779
|
artikel
|
| 65 |
De novo sarcomas in solid organ transplant recipients
|
Husted, T.L
|
|
2002
|
34 |
5 |
p. 1786-1787
|
artikel
|
| 66 |
15-deoxyspergualin protects the islet graft from macrophage-mediated injury
|
Juang, J.-H
|
|
2002
|
34 |
5 |
p. 1458-1459
|
artikel
|
| 67 |
Design and preliminary results of a randomized study on the conversion of treatment with calcineurin inhibitors to mycophenolate mofetil in chronic renal graft failure: effect, on serum cholesterol levels
|
Suwelack, B
|
|
2002
|
34 |
5 |
p. 1803-1805
|
artikel
|
| 68 |
Diabetes in renal transplant recipients treated with tacrolimus
|
Akioka, K
|
|
2002
|
34 |
5 |
p. 1774-1775
|
artikel
|
| 69 |
Does allopurinol prevent side effects of cyclosporine-A treatment?
|
Kobelt, V
|
|
2002
|
34 |
5 |
p. 1425-1427
|
artikel
|
| 70 |
Donor treatment improves survival of rat cardiac allografts in sensitized recipients
|
Schmidbauer, G.S
|
|
2002
|
34 |
5 |
p. 1477-1478
|
artikel
|
| 71 |
Early experience using calcineurin-free protocol in recipients of high-risk cadaver renal transplants
|
El-Sabrout, R
|
|
2002
|
34 |
5 |
p. 1627-1628
|
artikel
|
| 72 |
Early steroid withdrawal in renal transplantation with tacrolimus dual therapy: a pilot study
|
Boots, J.M.M
|
|
2002
|
34 |
5 |
p. 1698-1699
|
artikel
|
| 73 |
Effect of bile flow on the absorption of tacrolimus in liver allograft transplantation
|
Böttiger, Y
|
|
2002
|
34 |
5 |
p. 1544-1545
|
artikel
|
| 74 |
Effect of daclizumab, tacrolimus, and mycophenolate mofetil in pediatric first renal transplant recipients
|
Ciancio, G
|
|
2002
|
34 |
5 |
p. 1944-1945
|
artikel
|
| 75 |
Effect of daclizumab, tacrolimus and mycophenolate mofetil in racial minority first renal transplant recipients
|
Ciancio, G
|
|
2002
|
34 |
5 |
p. 1617-1618
|
artikel
|
| 76 |
Effect of immunosuppressive regimen on novel markers of atherothrombosis in heart transplantation: homocysteine, c-reactive protein, and mean platelet volume
|
Mehra, M.R
|
|
2002
|
34 |
5 |
p. 1866-1868
|
artikel
|
| 77 |
Effect of rapamycin in combination with calcineurin inhibitors, FK506 and cyclosporin, following arterial injury
|
Waller, J.R
|
|
2002
|
34 |
5 |
p. 1481-1483
|
artikel
|
| 78 |
Effects of adenoviral vectors containing CTLA4Ig-gene in rat heterotopic lung implants
|
Kita, Y
|
|
2002
|
34 |
5 |
p. 1434-1436
|
artikel
|
| 79 |
Effects of immunosuppressive regimens on plasma levels of transforming growth factor-beta 1 in renal transplant recipients
|
Pozzetto, U
|
|
2002
|
34 |
5 |
p. 1740-1742
|
artikel
|
| 80 |
Efficacy and safety of dual versus triple tacrolimus-based therapy in kidney transplantation: two-year follow-up
|
Garcia, I
|
|
2002
|
34 |
5 |
p. 1638-1639
|
artikel
|
| 81 |
Efficacy and safety of tacrolimus compared with cyclosporine microemulsion in kidney transplantation: twelve-month follow-up
|
Montagnino, G
|
|
2002
|
34 |
5 |
p. 1635-1637
|
artikel
|
| 82 |
Efficient gene transduction to cultured hepatocytes by HIV-1 derived lentiviral vector
|
Ohashi, K
|
|
2002
|
34 |
5 |
p. 1431-1433
|
artikel
|
| 83 |
Evidence that fasting does not significantly affect trough levels of tacrolimus in stable renal transplant recipients
|
van Duijnhoven, E.M
|
|
2002
|
34 |
5 |
p. 1723-1725
|
artikel
|
| 84 |
Excellent results following 3 years of tacrolimus immunosuppression in kidney transplantation recipients in japan: overall analysis of more than 1000 patients
|
Takahara, S
|
|
2002
|
34 |
5 |
p. 1597-1599
|
artikel
|
| 85 |
Excellent 3-year results following living-donor kidney transplantation and tacrolimus immunosuppression in japan
|
Uchida, K
|
|
2002
|
34 |
5 |
p. 1606-1607
|
artikel
|
| 86 |
Experience with the use of basiliximab in liver transplantation—use in pediatric and adult recipients in combination with cyclosporine or tacrolimus
|
Petz, W
|
|
2002
|
34 |
5 |
p. 1966-1967
|
artikel
|
| 87 |
Expression of high levels of soluble allogeneic major histocompatability complex class i antigen by adenoviral gene transfer strongly inhibits allospecific cytotoxic t lymphocytes in vivo
|
Graeb, C
|
|
2002
|
34 |
5 |
p. 1398-1399
|
artikel
|
| 88 |
Failure of Fas-ligand transgenic islets to resist allogeneic rejection
|
Juang, J.-H
|
|
2002
|
34 |
5 |
p. 1456-1457
|
artikel
|
| 89 |
First results from a prospective randomized trial comparing steroid-free induction therapy with tacrolimus and MMF versus tacrolimus and steroids in patients after liver transplantation for HCV
|
Langrehr, J.M
|
|
2002
|
34 |
5 |
p. 1565-1566
|
artikel
|
| 90 |
Five year outcome of tacrolimus rescue therapy in late rejection after renal transplantation
|
Budde, K
|
|
2002
|
34 |
5 |
p. 1594-1596
|
artikel
|
| 91 |
FK 506 abrogates induction of regulatory cells after intratracheal delivery of alloantigen
|
Shibutani, S
|
|
2002
|
34 |
5 |
p. 1445
|
artikel
|
| 92 |
FTY720: a novel approach to the treatment of hepatic ischemia-reperfusion injury
|
Anselmo, D.M
|
|
2002
|
34 |
5 |
p. 1467-1468
|
artikel
|
| 93 |
Gastric cancer in transplant recipients: detection of malignacy by aggressive endoscopy
|
Buell, J.F
|
|
2002
|
34 |
5 |
p. 1784-1785
|
artikel
|
| 94 |
Gemcitabine in models of acute and accelerated rejection
|
Jung, F
|
|
2002
|
34 |
5 |
p. 1420-1421
|
artikel
|
| 95 |
Gene expression profiling of acute rejection and mixed lymphocyte reaction with tacrolimus immunosuppression
|
Erickson, L.M
|
|
2002
|
34 |
5 |
p. 1385-1386
|
artikel
|
| 96 |
Heme oxygenase-1 gene transfer prevents CD95/fasl-mediated apoptosis and improves liver allograft survival via carbon monoxide signaling pathway
|
Ke, B
|
|
2002
|
34 |
5 |
p. 1465-1466
|
artikel
|
| 97 |
High level of TGF-β in organ transplantation might be due to rejection rather than calcineurin inhibitor medication
|
Wynn, C
|
|
2002
|
34 |
5 |
p. 1387-1389
|
artikel
|
| 98 |
Histopathological findings according to banff-97 classification system comparing tacrolimus versus cyclosporine
|
Rodrigo, E
|
|
2002
|
34 |
5 |
p. 1719-1720
|
artikel
|
| 99 |
Immunosuppression and merkel cell cancer
|
Buell, J.F
|
|
2002
|
34 |
5 |
p. 1780-1781
|
artikel
|
| 100 |
Immunosuppression and the prognosis of patients suffering from myeloproliferative disorders after liver transplantation
|
Bahr, M.J
|
|
2002
|
34 |
5 |
p. 1493-1494
|
artikel
|
| 101 |
Immunosuppression in cadaveric renal transplant recipients from non–heart-beating donors in a single center
|
Ushigome, H
|
|
2002
|
34 |
5 |
p. 1681-1682
|
artikel
|
| 102 |
Immunosuppression in cadaveric renal transplant recipients from non–heart-beating donors in a single center
|
Ushigome, H
|
|
2002
|
34 |
5 |
p. 1503
|
artikel
|
| 103 |
Immunosuppressive management following small bowel transplantation
|
Mueller, A.R
|
|
2002
|
34 |
5 |
p. 1894-1896
|
artikel
|
| 104 |
Immunosuppressive regimen in lung transplantation: initial intravenous mycophenolate mofetil and cyclosporine avoid cytolytic induction and allow for rapid steroid tapering
|
Fieguth, H.G
|
|
2002
|
34 |
5 |
p. 1879-1880
|
artikel
|
| 105 |
Immunosupressive agents and their actions
|
First, M.R
|
|
2002
|
34 |
5 |
p. 1369-1371
|
artikel
|
| 106 |
Impact of ACE polymorphism on renal allograft function, blood pressure, and proteinuria under ACE inhibition
|
Suwelack, B
|
|
2002
|
34 |
5 |
p. 1763-1766
|
artikel
|
| 107 |
Impact of HLA matching upon outcome after liver transplantation
|
Neumann, U.P
|
|
2002
|
34 |
5 |
p. 1499-1500
|
artikel
|
| 108 |
Impact of immunosuppressive regimen on cardiovascular risk factors in kidney transplant recipients
|
Boucher, A
|
|
2002
|
34 |
5 |
p. 1799-1802
|
artikel
|
| 109 |
Impact of noncompliance and donor/recipient race matching on chronic liver rejection
|
Haustein, S.V
|
|
2002
|
34 |
5 |
p. 1497-1498
|
artikel
|
| 110 |
Improved lipid profile and blood sugar control in pediatric renal transplant recipients using sirolimus-tacrolimus combination
|
El-Sabrout, R
|
|
2002
|
34 |
5 |
p. 1946-1947
|
artikel
|
| 111 |
Improved outcome of minor-mismatched living renal allografts under tacrolimus immunosuppression
|
Tanabe, K
|
|
2002
|
34 |
5 |
p. 1668-1670
|
artikel
|
| 112 |
Improvement of cardiovascular risk factors in heart transplant recipients after conversion from cyclosporine to tacrolimus: a role of the TGF-β system
|
van Riemsdijk, I.C
|
|
2002
|
34 |
5 |
p. 1864-1865
|
artikel
|
| 113 |
Improving results in solitary pancreas transplantation with portal-enteric drainage and thymoglobulin induction
|
Stratta, R.J
|
|
2002
|
34 |
5 |
p. 1915-1917
|
artikel
|
| 114 |
Incidence of cytomegalovirus infection and disease in orthotopic liver transplant patients immunosuppressed with cyclosporin versus tacrolimus
|
Varo, E
|
|
2002
|
34 |
5 |
p. 1567-1568
|
artikel
|
| 115 |
Incidence of cytomegalovirus infections after immunosuppression induction in clinical islet transplantation and impact on graft function
|
Eckhard, M
|
|
2002
|
34 |
5 |
p. 1922-1924
|
artikel
|
| 116 |
Increased acute rejection episodes among recipients of living unrelated donor compared with cadaver and living related donor renal transplants
|
Long, D.G
|
|
2002
|
34 |
5 |
p. 1673-1674
|
artikel
|
| 117 |
Increased frequency of lymphoceles under treatment with sirolimus following renal transplantation: a single center experience
|
Giessing, M
|
|
2002
|
34 |
5 |
p. 1815-1816
|
artikel
|
| 118 |
Induction of prolonged survival of fully allogeneic cardiac graft by intratracheal delivery of a single major histocompatability complex class i peptide
|
Akiyama, Y
|
|
2002
|
34 |
5 |
p. 1396-1397
|
artikel
|
| 119 |
Induction therapy for adult small bowel transplant with Campath-1H
|
Nishida, S
|
|
2002
|
34 |
5 |
p. 1889-1891
|
artikel
|
| 120 |
Induction therapy for small bowel transplant recipients: early experience in Birmingham, UK
|
Beath, S.V
|
|
2002
|
34 |
5 |
p. 1892-1893
|
artikel
|
| 121 |
Induction with basiliximab reduces acute rejection in pediatric liver transplant patients treated with tacrolimus and steroids
|
Asensio, M
|
|
2002
|
34 |
5 |
p. 1970-1971
|
artikel
|
| 122 |
Influence of antihypertensive drugs on renal microcirculation and renal hemodynamics in cyclosporine a-treated rats
|
Hillebrand, U
|
|
2002
|
34 |
5 |
p. 1383-1384
|
artikel
|
| 123 |
Influence of immunoprophylaxis on renal graft function and survival
|
Woodside, K.J
|
|
2002
|
34 |
5 |
p. 1619-1621
|
artikel
|
| 124 |
Influence of immunosuppressive drugs on intestinal epithelial transport function
|
Stockmann, M
|
|
2002
|
34 |
5 |
p. 1449-1450
|
artikel
|
| 125 |
Inhibition of epithelial replacement by nonspecific immunosuppressants accelerates rat orthotopic tracheal allograft rejection
|
Ito, Y
|
|
2002
|
34 |
5 |
p. 1441-1442
|
artikel
|
| 126 |
Inhibition of IL-12 signaling stat4/IFN-γ pathway by rapamycin is associated with impaired dendritc cell function
|
Chiang, P.-H
|
|
2002
|
34 |
5 |
p. 1394-1395
|
artikel
|
| 127 |
Interaction between tacrolimus and antiretroviral agents in human immunodeficiency virus–positive liver and kidney transplantation patients
|
Jain, A.K.B
|
|
2002
|
34 |
5 |
p. 1540-1541
|
artikel
|
| 128 |
Intestinal transplantation in children: Paris experience
|
Goulet, O
|
|
2002
|
34 |
5 |
p. 1887-1888
|
artikel
|
| 129 |
Intestinal transplantation including the colon in children
|
Goulet, O
|
|
2002
|
34 |
5 |
p. 1885-1886
|
artikel
|
| 130 |
Intravenous administration of antithrombin III induces indefinite survival of fully allogeneic cardiac grafts
|
Aramaki, O
|
|
2002
|
34 |
5 |
p. 1409-1410
|
artikel
|
| 131 |
In vivo test of two low doses of mycophenolate mofetil in an experimental model of islet allotransplantation
|
Xekouki, P
|
|
2002
|
34 |
5 |
p. 1446-1448
|
artikel
|
| 132 |
Is immunosuppression justified for nonuremic diabetic patients to keep them insulin independent? (The argument for)
|
Sutherland, D.E.R.
|
|
2002
|
34 |
5 |
p. 1927-1928
|
artikel
|
| 133 |
Islet cell transplantation: should we use more than one pancreas? Con
|
Burke, G.W
|
|
2002
|
34 |
5 |
p. 1925-1926
|
artikel
|
| 134 |
Is there a need for surveillance endomyocardial biopsies inheart transplantation?
|
Kirklin, J.K
|
|
2002
|
34 |
5 |
p. 1857-1859
|
artikel
|
| 135 |
Lectin staining for urine cytologic monitoring after kidney transplantation
|
Grupp, C
|
|
2002
|
34 |
5 |
p. 1751-1752
|
artikel
|
| 136 |
Lipid profiles after liver transplantation in patients receiving tacrolimus or cyclosporin
|
Aguirrezabalaga, J
|
|
2002
|
34 |
5 |
p. 1551-1552
|
artikel
|
| 137 |
Liver transplantation across ABO blood groups
|
Lang, M
|
|
2002
|
34 |
5 |
p. 1501-1502
|
artikel
|
| 138 |
Liver transplantation in infants: how much immunosuppression is needed?
|
Ganschow, R
|
|
2002
|
34 |
5 |
p. 1963
|
artikel
|
| 139 |
Liver transplantation in infants younger than 6 months old
|
Grabhorn, E
|
|
2002
|
34 |
5 |
p. 1964-1965
|
artikel
|
| 140 |
Liver transplant induction trial of daclizumab to spare calcineurin inhibition
|
Heffron, T.G
|
|
2002
|
34 |
5 |
p. 1514-1515
|
artikel
|
| 141 |
Local immunosuppression with kidney-targeting prednisolone prodrug prolong rat renal allograft survival
|
Su, M
|
|
2002
|
34 |
5 |
p. 1422-1424
|
artikel
|
| 142 |
Long-term graft acceptance after rat liver allograft transplantation induced by application of CTLA4-Ig and donor specific spleen cell administration
|
Neumann, U.P
|
|
2002
|
34 |
5 |
p. 1400-1401
|
artikel
|
| 143 |
Long-term outcome of tacrolimus in cadaveric kidney transplantation from non–heart-beating donors
|
Fukuhara, N.
|
|
2002
|
34 |
5 |
p. 1577-1579
|
artikel
|
| 144 |
Long-term results and complications of living related kidney transplantation in a single center
|
Yoshimura, N
|
|
2002
|
34 |
5 |
p. 1675-1677
|
artikel
|
| 145 |
Low-dose and rapid steroid withdrawal in renal transplant patients treated with tacrolimus and mycophenolate mofetil
|
Sola, E
|
|
2002
|
34 |
5 |
p. 1689-1690
|
artikel
|
| 146 |
Low-dose tacrolimus, trough-monitored mycophenolate mofetil, and planned steroid withdrawal for cadaveric kidney transplantation: a single center experience
|
Beaunoyer, M
|
|
2002
|
34 |
5 |
p. 1694-1695
|
artikel
|
| 147 |
Low incidence of graft arteriosclerosis after cardiac transplantation: risk factor analysis for patients with induction therapy
|
Zuckermann, A.
|
|
2002
|
34 |
5 |
p. 1869-1871
|
artikel
|
| 148 |
Low incidence of hypercholesterolemia among liver transplant patients under tacrolimus monotherapy immunosuppression
|
Charco, R
|
|
2002
|
34 |
5 |
p. 1555-1556
|
artikel
|
| 149 |
Low incidence of posttransplant lymphoproliferative disease in children treated with low-dose immunosuppression after liver transplantation
|
Ganschow, R
|
|
2002
|
34 |
5 |
p. 1961-1962
|
artikel
|
| 150 |
Macrophage blockade induced by repeated gadolinium chloride injections saves human fetal islet xenografting in rats
|
Farkas, G
|
|
2002
|
34 |
5 |
p. 1460-1461
|
artikel
|
| 151 |
Malignancy in organ transplantation:
|
Hunt, S.A
|
|
2002
|
34 |
5 |
p. 1874-1876
|
artikel
|
| 152 |
Medium-term outcome using sirolimus-tacrolimus combination in adult renal transplant recipients
|
Rashid, I
|
|
2002
|
34 |
5 |
p. 1649-1650
|
artikel
|
| 153 |
Microarray analysis of gene expression in peripheral blood mononuclear cells derived from long-surviving renal recipients
|
Zhang, H.Q
|
|
2002
|
34 |
5 |
p. 1757-1759
|
artikel
|
| 154 |
Microchimerism in patients after orthotopic liver transplantation: a prognostic indicator?
|
Junge, G
|
|
2002
|
34 |
5 |
p. 1542-1543
|
artikel
|
| 155 |
Monoterpene geraniol prevents acute allograft rejection
|
Ji, P
|
|
2002
|
34 |
5 |
p. 1418-1419
|
artikel
|
| 156 |
Mycophenolate mofetil reduces anti-HLA antibody production and cellular rejection in heart transplant recipients
|
Lietz, K
|
|
2002
|
34 |
5 |
p. 1828-1829
|
artikel
|
| 157 |
Mycophenolate mofetil reduces late renal allograft loss: a 4-year study
|
Nghiem, D.D
|
|
2002
|
34 |
5 |
p. 1683-1684
|
artikel
|
| 158 |
Mycophenolate mofetil without antibody induction in pediatric renal transplantation
|
Ojogho, O
|
|
2002
|
34 |
5 |
p. 1953-1954
|
artikel
|
| 159 |
Mycophenolate’s influence in the treatment of recurrent hepatitis c following liver transplantation
|
Smallwood, G.A
|
|
2002
|
34 |
5 |
p. 1559-1560
|
artikel
|
| 160 |
Noncompliance postrenal transplantation: measuring the extent of the problem using electronic surveillance and nurse practitioner interviews
|
Hardstaff, R
|
|
2002
|
34 |
5 |
p. 1608-1609
|
artikel
|
| 161 |
One year evolution of bone mineral density in kidney transplant recipients receiving tacrolimus versus cyclosporine
|
El Haggan, W
|
|
2002
|
34 |
5 |
p. 1817-1818
|
artikel
|
| 162 |
One-year follow-up of a brazilian randomized multicenter study comparing tacrolimus versus cyclosporine in kidney transplantation
|
Campos, H.H
|
|
2002
|
34 |
5 |
p. 1656-1658
|
artikel
|
| 163 |
One-year glomerular filtration rate predicts graft survival in pediatric renal recipients: a randomized trial of tacrolimus vs cyclosporine microemulsion
|
Filler, G
|
|
2002
|
34 |
5 |
p. 1935-1938
|
artikel
|
| 164 |
Optimal use of tacrolimus in living donor renal transplantation in children
|
Hasegawa, A
|
|
2002
|
34 |
5 |
p. 1939-1941
|
artikel
|
| 165 |
Oral dosing of tacrolimus and cyclosporine microemulsion—results from a large multicenter study in renal transplantation
|
Dietl, K.-H
|
|
2002
|
34 |
5 |
p. 1659-1660
|
artikel
|
| 166 |
Osteoporosis screening in an outpatient liver transplant clinic: impact of primary immunosuppression
|
Smallwood, G.A
|
|
2002
|
34 |
5 |
p. 1569-1570
|
artikel
|
| 167 |
Outcome of kidney transplantation from non–heart-beating donors followed by tacrolimus immunosuppression in japan
|
Tanabe, K
|
|
2002
|
34 |
5 |
p. 1580-1582
|
artikel
|
| 168 |
Pancreas transplantation in cross-match-positive recipients using cyclosporine- or tacrolimus-based immunosuppression
|
Khwaja, K
|
|
2002
|
34 |
5 |
p. 1901-1902
|
artikel
|
| 169 |
Patient profile and candidacy for intestinal transplantation at the University of Pittsburgh
|
Martin, D
|
|
2002
|
34 |
5 |
p. 1897-1898
|
artikel
|
| 170 |
Patients with high cholesterol levels benefit most from early withdrawal of corticosteroids
|
Rigotti, P
|
|
2002
|
34 |
5 |
p. 1797-1798
|
artikel
|
| 171 |
Patterns and outcomes for maintenance immunosuppression in the UNOS renal transplant registry
|
Takemoto, S.K
|
|
2002
|
34 |
5 |
p. 1632-1634
|
artikel
|
| 172 |
Pediatric liver transplantation in 808 consecutive children: 20-years experience from a single center
|
Jain, A
|
|
2002
|
34 |
5 |
p. 1955-1957
|
artikel
|
| 173 |
Peripheral lymphocyte subsets in the management of PTLD
|
Gupte, G.L
|
|
2002
|
34 |
5 |
p. 1782-1783
|
artikel
|
| 174 |
Pharmacodynamic monitoring of mycophenolate mofetil in stable renal allograft recipients
|
Budde, K
|
|
2002
|
34 |
5 |
p. 1748-1750
|
artikel
|
| 175 |
Pharmacodynamics of sirolimus in transplanted children receiving tacrolimus
|
Sindhi, R
|
|
2002
|
34 |
5 |
p. 1960
|
artikel
|
| 176 |
Pharmacokinetics and pharmacodynamics of mycophenolate mofetil under oral and intravenous therapy
|
Braun, K.-P
|
|
2002
|
34 |
5 |
p. 1745-1747
|
artikel
|
| 177 |
Pharmacokinetics of tacrolimus in heart transplantation
|
Undre, N.A
|
|
2002
|
34 |
5 |
p. 1836-1838
|
artikel
|
| 178 |
Pharmacokinetics of tacrolimus in paediatric renal transplant recipients
|
Webb, N.J.A
|
|
2002
|
34 |
5 |
p. 1948-1950
|
artikel
|
| 179 |
Pirfenidone inhibits early neointimal proliferation following arterial injury
|
Waller, J.R.
|
|
2002
|
34 |
5 |
p. 1486-1488
|
artikel
|
| 180 |
Polyomavirus in kidney and kidney–pancreas transplantation: a defined protocol for immunosuppression reduction and histologic monitoring
|
Trofe, J
|
|
2002
|
34 |
5 |
p. 1788-1789
|
artikel
|
| 181 |
Poor graft survival in patients historically positive for antidonor antibody after living related renal transplantations
|
Nanri, M
|
|
2002
|
34 |
5 |
p. 1583
|
artikel
|
| 182 |
Posttransplant diabetes mellitus after orthotopic liver transplantation
|
Stockmann, M
|
|
2002
|
34 |
5 |
p. 1571-1572
|
artikel
|
| 183 |
Predictors of early renal insufficiency in cardiac transplant recipients initiated on tacrolimus
|
Baran, D.A
|
|
2002
|
34 |
5 |
p. 1872-1873
|
artikel
|
| 184 |
Preemptive therapy with plasmapheresis/intravenous immunoglobulin allows successful live donor renal transplantation in patients with a positive cross-match
|
Sonnenday, C.J
|
|
2002
|
34 |
5 |
p. 1614-1616
|
artikel
|
| 185 |
Preface
|
Busuttil, Ronald W
|
|
2002
|
34 |
5 |
p. 1365
|
artikel
|
| 186 |
Pregnancy outcomes in female heart and heart-lung transplant recipients
|
Cowan, S.W
|
|
2002
|
34 |
5 |
p. 1855-1856
|
artikel
|
| 187 |
Preliminary immunosuppression withdrawal strategies with sirolimus in children with liver transplants
|
Sindhi, R
|
|
2002
|
34 |
5 |
p. 1972-1973
|
artikel
|
| 188 |
Primary immunosuppression with tacrolimus is associated with a reduction in renal allograft fibrosis compared with neoral therapy
|
Waller, J.R
|
|
2002
|
34 |
5 |
p. 1587-1588
|
artikel
|
| 189 |
Prospective analysis of thrombotic microangiopathy after renal transplantation: comparison between cyclosporine and tacrolimus immunosuppression
|
Tanabe, K
|
|
2002
|
34 |
5 |
p. 1819-1820
|
artikel
|
| 190 |
Prospective randomized pilot study of steroid withdrawal with mycophenolate mofetil in long-term cyclosporine-treated patients: 4-year follow-up
|
Budde, K
|
|
2002
|
34 |
5 |
p. 1703-1706
|
artikel
|
| 191 |
Prospective study of a tacrolimus-based quadruple immunosuppressive regimen: evaluation of safety and efficacy
|
Lladó, L
|
|
2002
|
34 |
5 |
p. 1526-1528
|
artikel
|
| 192 |
Randomized conversion from cyclosporine to tacrolimus in renal transplant patients: improved lipid profile and unchanged plasma homocysteine levels
|
Artz, M.A
|
|
2002
|
34 |
5 |
p. 1793-1794
|
artikel
|
| 193 |
Randomized trial of three different immunosuppressive regimens to prevent chronic renal allograft rejection
|
Burke, G.W
|
|
2002
|
34 |
5 |
p. 1610-1611
|
artikel
|
| 194 |
Rapamycin blocks the generation of regulatory t cells facilitated by posttransplant infusion of donor t cells through increasing the apoptosis of thymic CD4+CD25+ cells
|
Tsui, T.-Y
|
|
2002
|
34 |
5 |
p. 1390-1391
|
artikel
|
| 195 |
Recurrence of hepatitis c in liver transplant recipients treated with mycophenolate mofetil
|
Fasola, C.G
|
|
2002
|
34 |
5 |
p. 1563-1564
|
artikel
|
| 196 |
Regulatory t cells induced by allochimeric major histocompatability class i therapy inhibit allograft apoptosis
|
Semiletova, N
|
|
2002
|
34 |
5 |
p. 1402
|
artikel
|
| 197 |
Rejection-free protocol using sirolimus-tacrolimus combination for pediatric renal transplant recipients
|
El-Sabrout, R
|
|
2002
|
34 |
5 |
p. 1942-1943
|
artikel
|
| 198 |
Renal sparing effects of mycophenolate when used in long-term liver transplant receipients
|
Smallwood, G.A
|
|
2002
|
34 |
5 |
p. 1550
|
artikel
|
| 199 |
Replacement of calcineurin inhibitors by mycophenolate mofetil: effect on hemoglobine levels
|
Suwelack, B
|
|
2002
|
34 |
5 |
p. 1808-1809
|
artikel
|
| 200 |
Requirement of the costimulatory signal in xeno-MHC-restricted helper T-cell activation
|
Iwata, H
|
|
2002
|
34 |
5 |
p. 1453-1455
|
artikel
|
| 201 |
Risk-directed immunosuppression in heart transplant recipients: maintenance prednisone can be avoided in selected patients
|
Arnold, A.N
|
|
2002
|
34 |
5 |
p. 1830-1833
|
artikel
|
| 202 |
Risk of adrenal insufficiency with steroid maintenance therapy in renal transplantation
|
Boots, J.M.M
|
|
2002
|
34 |
5 |
p. 1696-1697
|
artikel
|
| 203 |
Safety analysis following tacrolimus immunosuppression in renal transplant recipients in Japan: 3-year results in over 1000 patients
|
Yoshimura, N
|
|
2002
|
34 |
5 |
p. 1600-1603
|
artikel
|
| 204 |
Safe withdrawal of corticosteroids or mycophenolate mofetil: results of a large, prospective, multicenter, randomized study
|
Squifflet, J.-P
|
|
2002
|
34 |
5 |
p. 1584-1586
|
artikel
|
| 205 |
Should priority on the waiting list be given to patients with diabetes: pro
|
Gruessner, R.W.G
|
|
2002
|
34 |
5 |
p. 1575-1576
|
artikel
|
| 206 |
Sialyl lewisx monitoring as an early detector of b-cell-dependent rejection
|
Ishida, H
|
|
2002
|
34 |
5 |
p. 1760-1762
|
artikel
|
| 207 |
Sirolimus and tacrolimus in clinical cardiac transplantation
|
Pham, S.M
|
|
2002
|
34 |
5 |
p. 1839-1842
|
artikel
|
| 208 |
Sirolimus-based immunosuppresive protocol for calcineurin sparing in liver transplantation
|
Heffron, T.G
|
|
2002
|
34 |
5 |
p. 1522-1523
|
artikel
|
| 209 |
Sirolimus-based steroid-free maintenance immunosuppression
|
Mital, D
|
|
2002
|
34 |
5 |
p. 1709-1710
|
artikel
|
| 210 |
Sirolimus inhibits growth of human hepatoma cells in contrast to tacrolimus which promotes cell growth
|
Schumacher, G
|
|
2002
|
34 |
5 |
p. 1392-1393
|
artikel
|
| 211 |
Stem cells and their clinical application
|
Domínguez-Bendala, J
|
|
2002
|
34 |
5 |
p. 1372-1375
|
artikel
|
| 212 |
Steroid-free regimen with daclizumab, mycophenolate mofetil, and tacrolimus in liver transplant recipients
|
Figueras, J
|
|
2002
|
34 |
5 |
p. 1511-1513
|
artikel
|
| 213 |
Steroid-resistant acute rejection following SPK: importance of maintaining therapeutic dosing in a triple-drug regimen
|
Burke III, G.W
|
|
2002
|
34 |
5 |
p. 1918-1919
|
artikel
|
| 214 |
Steroids may compromise quality of life of renal transplant recipients on a tacrolimus-based regimen
|
Moons, P
|
|
2002
|
34 |
5 |
p. 1691-1692
|
artikel
|
| 215 |
Steroid weaning in heart transplantation is associated with decreased b-type natriuretic peptide:
|
Uber, P.A
|
|
2002
|
34 |
5 |
p. 1843-1844
|
artikel
|
| 216 |
Steroid withdrawal from tacrolimus-based therapy in renal transplant patients
|
Citterio, F
|
|
2002
|
34 |
5 |
p. 1707-1708
|
artikel
|
| 217 |
Steroid withdrawal under tacrolimus for primary biliary cirrhosis, primary sclerosing cholangitis and autoimmune hepatitis after liver transplantation and long-term survival
|
Jain, A
|
|
2002
|
34 |
5 |
p. 1524-1525
|
artikel
|
| 218 |
Study of pharmacokinetic parameters of tacrolimus by different oral administration periods in renal transplantation
|
Saito, K
|
|
2002
|
34 |
5 |
p. 1726-1729
|
artikel
|
| 219 |
Successful results after 3 years’ tacrolimus immunosuppression in abo-incompatible kidney transplantation recipients in japan
|
Takahashi, K
|
|
2002
|
34 |
5 |
p. 1604-1605
|
artikel
|
| 220 |
Successful steroid withdrawal at the end of the 1st year after renal transplantion in mycophenolate mofetil-treated patients
|
Budde, K
|
|
2002
|
34 |
5 |
p. 1700-1702
|
artikel
|
| 221 |
Surveillance biopsies in heart and lung transplantation
|
Hummel, M
|
|
2002
|
34 |
5 |
p. 1860-1863
|
artikel
|
| 222 |
Synergistic effect of high-dose mizoribine and low-dose tacrolimus on renal allograft survival in nonhuman primates
|
Tanabe, K
|
|
2002
|
34 |
5 |
p. 1428
|
artikel
|
| 223 |
Tacrolimus and cardiac transplantation:
|
Baran, D.A
|
|
2002
|
34 |
5 |
p. 1845-1846
|
artikel
|
| 224 |
Tacrolimus and new onset diabetes mellitus: the effect of steroid weaning
|
Baran, D.A
|
|
2002
|
34 |
5 |
p. 1711-1712
|
artikel
|
| 225 |
Tacrolimus-associated posttransplant diabetes mellitus in renal transplant recipients: role of hepatitis c infection
|
Baid, S
|
|
2002
|
34 |
5 |
p. 1771-1773
|
artikel
|
| 226 |
Tacrolimus-based immunosuppression in renal transplantation: 78 experiences in a single japanese center
|
Okamoto, M
|
|
2002
|
34 |
5 |
p. 1666-1667
|
artikel
|
| 227 |
Tacrolimus for treatment of bronchiolitis obliterans syndrome after unilateral and bilateral lung transplantation
|
Fieguth, H.G
|
|
2002
|
34 |
5 |
p. 1884
|
artikel
|
| 228 |
Tacrolimus inhibits platelet-derived growth factor ligand and receptor induction as well as rejection changes in rat renal allografts during long-term follow-up
|
Savikko, J
|
|
2002
|
34 |
5 |
p. 1382
|
artikel
|
| 229 |
Tacrolimus is associated with a lower incidence of cardiovascular complications in liver transplant recipients
|
Rabkin, J.M
|
|
2002
|
34 |
5 |
p. 1557-1558
|
artikel
|
| 230 |
Tacrolimus is effective in both dual and triple regimens after liver transplantation
|
Serrano, J
|
|
2002
|
34 |
5 |
p. 1529-1530
|
artikel
|
| 231 |
Tacrolimus monotherapy in renal transplantation: four-year data
|
Coupes, B.M
|
|
2002
|
34 |
5 |
p. 1612-1613
|
artikel
|
| 232 |
Tacrolimus/mycophenolate mofetil vs cyclosporine A/Azathioprine after simultaneous pancreas and kidney transplantation: five-year results of a randomized study
|
Woeste, G
|
|
2002
|
34 |
5 |
p. 1920-1921
|
artikel
|
| 233 |
Tacrolimus treats ongoing allograft rejection by inhibiting interleukin-10 mediated functional cytotoxic cell infiltration
|
Ebbs, A
|
|
2002
|
34 |
5 |
p. 1378-1381
|
artikel
|
| 234 |
Tacrolimus trough level adjustment after administration of fluconazole to kidney recipients
|
Toda, F
|
|
2002
|
34 |
5 |
p. 1733-1735
|
artikel
|
| 235 |
Tacrolimus versus cyclosporine in primary simultaneous pancreas-kidney transplantation: preliminary results at 1 year of a large multicenter trial
|
Land, W
|
|
2002
|
34 |
5 |
p. 1911-1912
|
artikel
|
| 236 |
Targeting the ERK-1/2 signalling pathway results in alloantigen-specific anergy in human t cells
|
Krieger, P.-M
|
|
2002
|
34 |
5 |
p. 1403-1404
|
artikel
|
| 237 |
Ten-year results of a randomised prospective study of FK506 versus cyclosporine in management of primary orthotopic liver transplantation
|
Chen, J.W.C
|
|
2002
|
34 |
5 |
p. 1507-1510
|
artikel
|
| 238 |
The case against less rejection with portal venous drainage and pancreas transplantation
|
Henry, M.L
|
|
2002
|
34 |
5 |
p. 1899-1900
|
artikel
|
| 239 |
The case against protocol kidney biopsies
|
Ponticelli, C
|
|
2002
|
34 |
5 |
p. 1716-1718
|
artikel
|
| 240 |
The case for protocol kidney biopsies
|
Isoniemi, H
|
|
2002
|
34 |
5 |
p. 1713-1715
|
artikel
|
| 241 |
The choice of calcineurin inhibitor does not influence centrilobular necrosis after orthotopic liver transplantation
|
Hassoun, Z
|
|
2002
|
34 |
5 |
p. 1519-1520
|
artikel
|
| 242 |
The effect of evening administration of prednisolone on postrenal transplant diabetes mellitus patients
|
Amada, N
|
|
2002
|
34 |
5 |
p. 1776-1777
|
artikel
|
| 243 |
The impact of donor factors on the outcomes following liver transplantation
|
Buell, J.F
|
|
2002
|
34 |
5 |
p. 1495-1496
|
artikel
|
| 244 |
The number of peripheral CD4CD25 cells and early postoperative episodes in renal transplantation
|
Satoh, S
|
|
2002
|
34 |
5 |
p. 1755-1756
|
artikel
|
| 245 |
Therapeutic drug monitoring of tacrolimus early after liver transplantation
|
Braun, F
|
|
2002
|
34 |
5 |
p. 1538-1539
|
artikel
|
| 246 |
The role of tissue factor in renal ischemic reperfusion injury by antisense oligodeoxynucleotide
|
Matsuyama, M
|
|
2002
|
34 |
5 |
p. 1475-1476
|
artikel
|
| 247 |
Thirteen years’ experience in pediatric liver transplantation: differences between tacrolimus and cyclosporine
|
Zajicek, A
|
|
2002
|
34 |
5 |
p. 1976-1978
|
artikel
|
| 248 |
Tolerance induction following orthotopic rat liver transplantation: cytokine production by CD4+ t cells determines the immunological response
|
Gassel, H.-J
|
|
2002
|
34 |
5 |
p. 1429-1430
|
artikel
|
| 249 |
Two-hour blood tacrolimus levels are not superior to trough levels as estimates of the area under the curve in tacrolimus-treated renal transplant patients
|
Jørgensen, K.A
|
|
2002
|
34 |
5 |
p. 1721-1722
|
artikel
|
| 250 |
Two-year outcome in renal allograft recipients comparing neoral-led with tacrolimus-led therapy
|
Wayman, M.R
|
|
2002
|
34 |
5 |
p. 1663-1665
|
artikel
|
| 251 |
Usefulness of cooling perfusion apparatus in cadaveric kidney perfusion
|
Hattori, R
|
|
2002
|
34 |
5 |
p. 1469-1472
|
artikel
|
| 252 |
Usefulness of monitoring of AUC0–4h during the induction period of immunosuppressive therapy with tacrolimus after renal transplantation
|
Uchida, K
|
|
2002
|
34 |
5 |
p. 1736-1737
|
artikel
|
| 253 |
Use of calcineurin inhibitors in pediatric liver transplantation: a single-center experience
|
Taylor, R.M
|
|
2002
|
34 |
5 |
p. 1974-1975
|
artikel
|
| 254 |
Use of mycophenolate mofetil in liver transplant recipients experiencing renal dysfunction on cyclosporine or tacrolimus—randomized, prospective, multicenter study results
|
Hodge, E.E
|
|
2002
|
34 |
5 |
p. 1546-1547
|
artikel
|
| 255 |
Value of mycophenolic acid trough level monitoring after lung transplantation
|
Devyatko, E
|
|
2002
|
34 |
5 |
p. 1881-1883
|
artikel
|
Tijdschrift beschrijving